Emcure Pharmaceuticals Limited — Others, 25-06-2025: Action(s) initiated or orders passed

Emcure Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year. The company disclosed that the Regional Director, Ministry of Corporate Affairs, has compounded a past procedural lapse related to director retirements during the 2015 and 2016 AGMs by imposing a compounding fee of Rs. 1.75 lakh, paid by the directors from their own funds. This settlement closes the matter with no material impact on Emcure’s financials or operations. This clarity supports governance compliance, reassuring shareholders about the company’s oversight.